Showing results (61-70 of 384) with videos related to
Sort By:
Pageof 39
Expert Opinion on Investigational Drugs|April 24, 2019
Pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaFlorence E Chamberlain, Chris Wilding, Robin L Jones, et al.Frontiers in Cell and Developmental Biology|December 27, 2021
The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular SignallingValeriya Pankova, Khin Thway, Robin L Jones, et al.NPJ Precision Oncology|March 6, 2021
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomasEve Merry, Khin Thway, Robin L Jones, et al.Expert Review of Gastroenterology & Hepatology|January 16, 2023
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumorsAmalya Sargsyan, Monika A Kucharczyk, Robin L Jones, et al.Expert Review of Anticancer Therapy|May 1, 2020
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtypeJavier Martín-Broto, Peter Reichardt, Robin L Jones, et al.Future Oncology (London, England)|February 3, 2021
Extraskeletal osteosarcomas: current updateAbhay K Kattepur, Ashish Gulia, Robin L Jones, et al.Signal Transduction and Targeted Therapy|May 25, 2019
Pazopanib in advanced soft tissue sarcomasAlex T J Lee, Robin L Jones, Paul H HuangJournal of Women'S Health (2002)|May 25, 2012
Reducing maternal deaths through state maternal mortality reviewSarah J Kilpatrick, Patricia Prentice, Robin L Jones, et al.Expert Review of Anticancer Therapy|November 25, 2021
Risk factors for the development of local recurrence in extremity soft-tissue sarcomaFabio Tirotta, Raza Sayyed, Robin L Jones, et al.Current Opinion in Oncology|April 30, 2021
Next-generation sequencing for the management of sarcomas with no known driver mutationsSimon Vyse, Khin Thway, Paul H Huang, et al.Pageof 39